James F. Polewaczyk, Executive Vice President at IDEXX LABORATORIES INC /DE (IDXX), sold 45,318 shares at $511.22 ($23.1M) on 2023-08-29, disclosed to the SEC on 2023-08-31.
Open-market sale of $23.1M IDXX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $508.96 | 500 | $254K | 1.1% |
| 2 | $509.32 | 2,545 | $1.3M | 5.6% |
| 3 | $509.32 | 2,545 | $1.3M | 5.6% |
| 4 | $510.38 | 6,186 | $3.2M | 13.6% |
| 5 | $510.38 | 6,186 | $3.2M | 13.6% |
| 6 | $510.47 | 3,318 |
| $1.7M |
| 7.3% |
| 7 | $510.47 | 3,318 | $1.7M | 7.3% |
| 8 | $511.03 | 7,473 | $3.8M | 16.5% |
| 9 | $511.03 | 7,473 | $3.8M | 16.5% |
| 10 | $511.22 | 2,887 | $1.5M | 6.4% |
| 11 | $511.22 | 2,887 | $1.5M | 6.4% |
| Total | $510.58 avg | 45,318 | $23.1M | 100% |
| Filing → |
| IDXX | SELL | 2021-12-01 | $2.9M | — | Filing → |
| IDXX | SELL | 2021-06-01 | $11.2M | — | Filing → |
| IDXX | SELL | 2020-05-12 | $9.7M | — | Filing → |